Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 7, 2019; 25(1): 118-137
Published online Jan 7, 2019. doi: 10.3748/wjg.v25.i1.118
Published online Jan 7, 2019. doi: 10.3748/wjg.v25.i1.118
Table 2 Predictive factors for complete pathological response in multivariate logistic regression analysis for all patients
Variable | P-value | OR | 95%CI | |
Age (yr) | ≤ 60 | 0.703 | 0.873 | 0.434-1.756 |
> 60 | 1 | |||
Differentiation | Well | 0.003 | 2.966 | 1.449-6.069 |
Moderate-poor | 1 | |||
TL (cm) | ≤ 3 | 0.004 | 2.608 | 1.347-5.052 |
> 3 | 1 | |||
DTAV | ≥ 5 | 0.07 | 0.56 | 0.299-1.049 |
< 5 | 1 | |||
MRF | - | 0.017 | 2.729 | 1.199-6.211 |
+ | 1 | |||
NT regimen | mFOLFOX6-RT | 0 | 5.339 | 2.394-11.903 |
mFOLFOX6 | 0.402 | 1.821 | 0.449-7.387 | |
Capecitabine/de Gramont-RT | 1 | |||
The interval | 0.093 | 1.029 | 0.995-1.064 |
- Citation: Ren DL, Li J, Yu HC, Peng SY, Lin WD, Wang XL, Ghoorun RA, Luo YX. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol 2019; 25(1): 118-137
- URL: https://www.wjgnet.com/1007-9327/full/v25/i1/118.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i1.118